Multicenter phase II study of pembrolizumab (P) in advanced soft tissue (STS) and bone sarcomas (BS): Final results of SARC028 and biomarker analyses Meeting Abstract
| Authors: | Burgess, M. A.; Bolejack, V.; Van Tine, B. A.; Schuetze, S.; Hu, J.; D'Angelo, S. P.; Attia, S.; Priebat, D. A.; Okuno, S. H.; Riedel, R. F.; Davis, L. E.; Mowa, S.; Reed, D. R.; Butterfield, L. H.; Roszik, J.; Reinke, D. K.; Baker, L. H.; Maki, R. G.; Patel, S.; Tawbi, H. A. H. |
| Abstract Title: | Multicenter phase II study of pembrolizumab (P) in advanced soft tissue (STS) and bone sarcomas (BS): Final results of SARC028 and biomarker analyses |
| Meeting Title: | 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 35 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2017 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2017-05-20 |
| Start Page: | 556s |
| Language: | English |
| ACCESSION: | WOS:000411932206159 |
| DOI: | 10.1200/JCO.2017.35.15_suppl.11008 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 11008 -- Source: Wos |
